CAR Macrophages for cancer immunotherapy enters phase 1 trial
The Scientist - 26-Mar-2021Gene modified macrophages may surpass CAR T cells in treating solid tumors
Join the club for FREE to access the whole archive and other member benefits.
Freelance science writer
Amanda Heidt is a freelancing science and environmental journalist based in Moab, Utah. She has a master’s degree in marine science from Moss Landing Marine Laboratories and a master’s degree in science communication from UC Santa Cruz. Her work has appeared online on Science, The Scientist, KQED Science, Deep Look, Inside Science, Discover Magazine, Eos, Geospace and Mongabay and in print in The Scientist, The San Jose Mercury News, Eos, The Santa Cruz Sentinel, The Monterey Herald, The East Bay Times and The Good Times.
Visit website: https://www.amandaheidt.com
Details last updated 23-Jan-2021
Gene modified macrophages may surpass CAR T cells in treating solid tumors
Derived from bacterial toxin - can make single base pair changes